/term/bs-deferred-policy-acquisition-costs/STU:4XB XBiotech (STU:4XB) Deferred Policy Acquisition Costs
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » XBiotech Inc (STU:4XB) » Definitions » Deferred Policy Acquisition Costs

XBiotech (STU:4XB) Deferred Policy Acquisition Costs


View and export this data going back to 2015. Start your Free Trial

What is XBiotech Deferred Policy Acquisition Costs?

Deferred Policy Acquisition Costs only applies to banks and insurance companies.

XBiotech (STU:4XB) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » XBiotech Inc (STU:4XB) » Definitions » Deferred Policy Acquisition Costs
Comparable Companies
INMB ANNX XFOR TALS LBPH PBYI CTXR RVPH GALT ADAP OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
XBIT:USA 4XB:Germany
Address
5217 Winnebago Lane, Austin, TX, USA, 78744
Website
http://www.xbiotech.com
XBiotech Inc is a United States based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States.